Zepbound vs Wegovy vs Saxenda: Which GLP-1 Is Best for You?
Zepbound vs Wegovy vs Saxenda: Which GLP-1 Is Best for You?

Introduction
If you’re researching prescription weight loss injections, three top contenders dominate the GLP-1 space: Zepbound, Wegovy, and Saxenda. All are FDA-approved and effective, but they differ in how they work, how often they’re taken, and how much weight you can expect to lose.
This guide compares Zepbound vs Wegovy vs Saxenda to help you decide which option best fits your lifestyle, goals, and health needs.
Snapshot Comparison
Feature |
Zepbound |
Wegovy |
Saxenda |
Active Ingredient |
Tirzepatide |
Semaglutide |
Liraglutide |
Hormones Targeted |
GLP-1 + GIP |
GLP-1 only |
GLP-1 only |
FDA Approval |
2023 |
2021 |
2014 |
Injection Frequency |
Weekly |
Weekly |
Daily |
Avg. Weight Loss |
15–22.5% |
10–16% |
5–8% |
Effectiveness
Medication |
Avg. Weight Loss |
Duration |
Trial Source |
Zepbound |
Up to 22.5% |
72 weeks |
|
Wegovy |
14.9% |
68 weeks |
|
Saxenda |
5–8% |
56 weeks |
Zepbound consistently delivers the most weight loss, followed by Wegovy, then Saxenda.
Dosing Convenience
Feature |
Zepbound |
Wegovy |
Saxenda |
Dosing |
Weekly |
Weekly |
Daily |
Device |
Single-use pen |
Single-use pen |
Multi-dose pen |
Best For |
Busy schedules |
Steady progress |
Routine takers |
If daily injections feel overwhelming, Zepbound or Wegovy may be easier to maintain.
Hormonal Action
- Zepbound: Dual-action GLP-1 + GIP = stronger metabolic response and satiety
- Wegovy & Saxenda: GLP-1 only = appetite suppression, delayed gastric emptying, better insulin regulation
Zepbound’s dual-hormone mechanism may be more effective for insulin resistance, PCOS, or stubborn fat.
Side Effects
All three may cause:
- Nausea
- Constipation
- Bloating
- Fatigue
- Injection site irritation
Rare risks include gallbladder issues or thyroid C-cell tumors (black box warning). None should be used in people with MEN-2 or a family history of medullary thyroid cancer.
Cost & Insurance
Medication |
U.S. Price |
Canadian Price |
Savings Card |
Covered by Insurance? |
Zepbound |
~$1,060/mo |
~$450–$500 |
|
|
Wegovy |
~$1,350/mo |
~$599–$699 |
|
|
Saxenda |
~$1,200/mo |
~$500–$700 |
|
Saxenda and Wegovy tend to be easier to get covered, while Zepbound may require more documentation.
Who Should Choose Zepbound?
Best for:
- People with 30+ pounds to lose
- Those with insulin resistance, PCOS, or prediabetes
- Users who want weekly injections
- People who didn’t get results from other GLP-1s
Who Should Choose Wegovy?
Best for:
- Users who want a weekly GLP-1
- Have insurance coverage for semaglutide
- Prefer a more established, single-hormone approach
- Are switching from Ozempic for weight loss
Who Should Choose Saxenda?
Best for:
- Users okay with daily injections
- Those who had success on Victoza (same drug)
- People with strong insurance coverage for Saxenda
- Users seeking a well-established option with mild appetite suppression
Final Thoughts
All three medications are powerful tools for weight loss. Your best option depends on your body, budget, and commitment to dosing.
Zepbound = highest weight loss, weekly, dual-action
Wegovy = strong weight loss, weekly, widely covered
Saxenda = reliable, daily, for lighter goals or coverage needs
Visit our GLP-1 Comparison Hub to download side-by-side charts and check your eligibility for savings cards.